Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vexer 75 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Vexer 75

Approved

STANDARD

Vexer 75

Akums Drugs & Pharmaceuticals Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 4330e41f0010f1fe
Company: Akums Drugs & Pharmaceuticals Ltd.
Type: Standard

Approval Details

Approval Id: 4330e41f0010f1fe
Drug Approval Philippines Name: Vexer 75
Product Name: Vexer 75
Registration Number: DR-XY43500
Brand Name: Vexer 75
Generic Name: Pregabalin
Dosage Form: Capsule
Dosage Strength: 75mg
Manufacturer: Akums Drugs & Pharmaceuticals Ltd.
Trader: Vexxa Lifeciences Pvt. Ltd.
Importer: VE Pharma, Inc.
Distributor: VE Pharma, Inc.
Company Detail Path: /organization/akums-drugs-and-pharmaceuticals-ltd
Issuance Date: 27 October 2023
Expiry Date: 27 June 2029
Pharmacologic Category: Anti-epileptic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

4330e41f0010f1fe

Type

Standard

Back to Philippines FDA Approvals